Trending News
News

News
Mass Spectrometry Strategies in Metabolomics
In this mini review, researchers from The Samuel Roberts Noble Foundation review various mass spectrometry technologies utilized in metabolomics and suggest future needs.

News
Emerging Tactical Strategies for Fighting the War on Cancer Based on the Genetic Landscape
This article discusses several high impact areas of global sequencing projects including developing drugs that specifically target cancer cells.

News
Fifteen US plant scientists win huge grants - $75M
Fifteen of US's most innovative plant scientists to join a new initiative that boosts much needed funding for fundamental plant science research.

News
What Makes A Plant A Plant?
Scientists have identified a list of proteins encoded in the genomes of plants and green algae, but not in the genomes of organisms that don't generate energy through photosynthesis

News
IDBS Leads Stratified Medicine Consortium
The UK’s national innovation agency, the Technology Strategy Board, has selected an IDBS-led consortium to create an informatics platform to support stratified and translational medicine research and cross-organizational collaboration.

News
Protein Attributes Contribute To Halo-Stability, Bioinformatics Approach
In this article researchers have examined protein features that contribute to the halo-toleration of halophilic organisms.

News
Building Protein-Protein Interaction Networks with Proteomic and Informatics Tools
This review focuses on the recent development of protein interaction networks derived from quantitative proteomics datasets.

News
USPTO Grants Two New Patents to Metabolon
Metabolon currently holds 17 US Patents related to its biochemical profiling methods, data analysis solutions and biomarkers for disease and toxicity.

News
AVI BioPharma and NMRC Successfully Complete Simultaneous Rapid-Response Exercises Against Bacterial and Viral Threats in 18 Days
PMO-based platform chemistries used by AVI to design and manufacture novel RNA-based drug candidates against both undisclosed bacterial and viral targets.

News
Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma
The Phase I/II, two cohort, open label clinical trial in metastatic melanoma opens at Washington University, St. Louis, Missouri.
Advertisement